Abstract:Event cameras have emerged as a promising vision sensor in recent years due to their unparalleled temporal resolution and dynamic range. While registration of 2D RGB images to 3D point clouds is a long-standing problem in computer vision, no prior work studies 2D-3D registration for event cameras. To this end, we propose E2PNet, the first learning-based method for event-to-point cloud registration. The core of E2PNet is a novel feature representation network called Event-Points-to-Tensor (EP2T), which encodes event data into a 2D grid-shaped feature tensor. This grid-shaped feature enables matured RGB-based frameworks to be easily used for event-to-point cloud registration, without changing hyper-parameters and the training procedure. EP2T treats the event input as spatio-temporal point clouds. Unlike standard 3D learning architectures that treat all dimensions of point clouds equally, the novel sampling and information aggregation modules in EP2T are designed to handle the inhomogeneity of the spatial and temporal dimensions. Experiments on the MVSEC and VECtor datasets demonstrate the superiority of E2PNet over hand-crafted and other learning-based methods. Compared to RGB-based registration, E2PNet is more robust to extreme illumination or fast motion due to the use of event data. Beyond 2D-3D registration, we also show the potential of EP2T for other vision tasks such as flow estimation, event-to-image reconstruction and object recognition. The source code can be found at: https://github.com/Xmu-qcj/E2PNet.
Abstract:Adenosine triphosphate (ATP) is a high-energy phosphate compound and the most direct energy source in organisms. ATP is an essential biomarker for evaluating cell viability in biology. Researchers often use ATP bioluminescence to measure the ATP of organoid after drug to evaluate the drug efficacy. However, ATP bioluminescence has some limitations, leading to unreliable drug screening results. Performing ATP bioluminescence causes cell lysis of organoids, so it is impossible to observe organoids' long-term viability changes after medication continually. To overcome the disadvantages of ATP bioluminescence, we propose Ins-ATP, a non-invasive strategy, the first organoid ATP estimation model based on the high-throughput microscopic image. Ins-ATP directly estimates the ATP of organoids from high-throughput microscopic images, so that it does not influence the drug reactions of organoids. Therefore, the ATP change of organoids can be observed for a long time to obtain more stable results. Experimental results show that the ATP estimation by Ins-ATP is in good agreement with those determined by ATP bioluminescence. Specifically, the predictions of Ins-ATP are consistent with the results measured by ATP bioluminescence in the efficacy evaluation experiments of different drugs.